These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 30314570)
1. Potential roles for opioid receptors in motivation and major depressive disorder. Callaghan CK; Rouine J; O'Mara SM Prog Brain Res; 2018; 239():89-119. PubMed ID: 30314570 [TBL] [Abstract][Full Text] [Related]
2. Dopamine dysregulation hypothesis: the common basis for motivational anhedonia in major depressive disorder and schizophrenia? Szczypiński JJ; Gola M Rev Neurosci; 2018 Sep; 29(7):727-744. PubMed ID: 29573379 [TBL] [Abstract][Full Text] [Related]
3. Anhedonia as a central factor in depression: Neural mechanisms revealed from preclinical to clinical evidence. Wang S; Leri F; Rizvi SJ Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110289. PubMed ID: 33631251 [TBL] [Abstract][Full Text] [Related]
4. Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response. Peciña M; Sikora M; Avery ET; Heffernan J; Peciña S; Mickey BJ; Zubieta JK Eur Neuropsychopharmacol; 2017 Oct; 27(10):977-986. PubMed ID: 28870407 [TBL] [Abstract][Full Text] [Related]
5. Feeding-modulatory effects of mu-opioids in the medial prefrontal cortex: a review of recent findings and comparison to opioid actions in the nucleus accumbens. Selleck RA; Baldo BA Psychopharmacology (Berl); 2017 May; 234(9-10):1439-1449. PubMed ID: 28054099 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of opioid systems in the hypothalamus as well as the mesolimbic area suppresses feeding behavior of mice. Ikeda H; Ardianto C; Yonemochi N; Yang L; Ohashi T; Ikegami M; Nagase H; Kamei J Neuroscience; 2015 Dec; 311():9-21. PubMed ID: 26454026 [TBL] [Abstract][Full Text] [Related]
7. Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? Puryear CB; Brooks J; Tan L; Smith K; Li Y; Cunningham J; Todtenkopf MS; Dean RL; Sanchez C Neurosci Biobehav Rev; 2020 Jan; 108():658-678. PubMed ID: 31821832 [TBL] [Abstract][Full Text] [Related]
9. Nucleus accumbens in the pathogenesis of major depressive disorder: A brief review. Jiang Y; Zou M; Wang Y; Wang Y Brain Res Bull; 2023 May; 196():68-75. PubMed ID: 36889362 [TBL] [Abstract][Full Text] [Related]
11. Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward. David V; Matifas A; Gavello-Baudy S; Decorte L; Kieffer BL; Cazala P Neuropsychopharmacology; 2008 Jun; 33(7):1746-59. PubMed ID: 17895918 [TBL] [Abstract][Full Text] [Related]
12. Circuit-based frameworks of depressive behaviors: The role of reward circuitry and beyond. Knowland D; Lim BK Pharmacol Biochem Behav; 2018 Nov; 174():42-52. PubMed ID: 29309799 [TBL] [Abstract][Full Text] [Related]
13. Bidirectional effects of opioids in motivational processes and the involvement of D1 dopamine receptors. Herz A NIDA Res Monogr; 1988; 90():17-26. PubMed ID: 2855853 [TBL] [Abstract][Full Text] [Related]
14. It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder. Hsu DT; Sanford BJ; Meyers KK; Love TM; Hazlett KE; Walker SJ; Mickey BJ; Koeppe RA; Langenecker SA; Zubieta JK Mol Psychiatry; 2015 Feb; 20(2):193-200. PubMed ID: 25600108 [TBL] [Abstract][Full Text] [Related]
15. Motivational deficits in effort-based decision making in individuals with subsyndromal depression, first-episode and remitted depression patients. Yang XH; Huang J; Zhu CY; Wang YF; Cheung EF; Chan RC; Xie GR Psychiatry Res; 2014 Dec; 220(3):874-82. PubMed ID: 25262638 [TBL] [Abstract][Full Text] [Related]
16. μ and κ opioid receptor distribution in the monogamous titi monkey (Callicebus cupreus): implications for social behavior and endocrine functioning. Ragen BJ; Freeman SM; Laredo SA; Mendoza SP; Bales KL Neuroscience; 2015 Apr; 290():421-34. PubMed ID: 25637809 [TBL] [Abstract][Full Text] [Related]
17. Impact of insulin and insulin resistance on brain dopamine signalling and reward processing - An underexplored mechanism in the pathophysiology of depression? Gruber J; Hanssen R; Qubad M; Bouzouina A; Schack V; Sochor H; Schiweck C; Aichholzer M; Matura S; Slattery DA; Zopf Y; Borgland SL; Reif A; Thanarajah SE Neurosci Biobehav Rev; 2023 Jun; 149():105179. PubMed ID: 37059404 [TBL] [Abstract][Full Text] [Related]
18. Neural mechanisms of reinforcement learning in unmedicated patients with major depressive disorder. Rothkirch M; Tonn J; Köhler S; Sterzer P Brain; 2017 Apr; 140(4):1147-1157. PubMed ID: 28334960 [TBL] [Abstract][Full Text] [Related]
19. Dopamine System Dysregulation in Major Depressive Disorders. Belujon P; Grace AA Int J Neuropsychopharmacol; 2017 Dec; 20(12):1036-1046. PubMed ID: 29106542 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates. Ahmad T; Laviolette SR Psychopharmacology (Berl); 2017 Aug; 234(15):2325-2336. PubMed ID: 28669034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]